Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of Myfortic and sirolimus
is effective at preventing rejection while preserving kidney function in stable kidney
transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
California Pacific Medical Center Research Institute